NRSNVSXXII• 28 Days (Normalized)
NRSN vs XXII (NeuroSense Therapeutics Ltd. vs 22nd Century Group Inc.)
Showing Closing Date Range from Sep 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NRSN Performance $4.78
+1063.02%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
XXII Performance $1.33
+%
22nd Century Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
+1063.02 pts
NRSN outperforming by 1063.02 percentage points
NRSNXXII
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NRSN XXII
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(19 dates)
| Date | NRSN Price | NRSN Gain (%) | XXII Price | XXII Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $4.78 | +1063.02% | $- | - | |
| Sep 28, 2026 | $5.10 | +1140.88% | $- | - | |
| Sep 25, 2026 | $6.95 | +1591.00% | $1.33 | -43.16% | +1634.16% |
| Sep 24, 2026 | $7.40 | +1700.49% | $1.51 | -35.47% | +1735.96% |
| Sep 23, 2026 | $7.40 | +1700.49% | $2.34 | +0.00% | +1700.49% |
| Sep 22, 2026 | $7.18 | +1646.96% | $1.81 | -22.65% | +1669.61% |
| Sep 21, 2026 | $6.62 | +1510.71% | $1.77 | -24.36% | +1535.07% |
| Sep 18, 2026 | $6.35 | +1445.01% | $1.79 | -23.50% | +1468.51% |
| Sep 17, 2026 | $6.72 | +1535.04% | $1.77 | -24.36% | +1559.40% |
| Sep 16, 2026 | $6.49 | +1479.08% | $1.72 | -26.50% | +1505.58% |
| Sep 15, 2026 | $7.03 | +1610.46% | $1.80 | -23.29% | +1633.75% |
| Sep 14, 2026 | $6.90 | +1578.83% | $1.85 | -20.94% | +1599.77% |
| Sep 11, 2026 | $0.35 | -15.57% | $1.99 | -14.96% | -0.61% |
| Sep 10, 2026 | $0.33 | -19.22% | $2.05 | -12.61% | -6.61% |
| Sep 09, 2026 | $0.40 | -2.43% | $2.13 | -8.97% | +6.54% |
Page 1 of 2